Inducements Procedure

Similar documents
Briefing note. ESMA Q&A on MiFID II inducements rules (research) (Latest update by ESMA: 23 March 2018)

Summary of Inducements Policy

GUIDE ON THE NEW RULES GOVERNING THE FUNDING OF RESEARCH BY INVESTMENT SERVICE PROVIDERS UNDER MIFID II January 2018

MIFID II Level 2 (draft ) Item 3. Investor protection issues

Miton Asset Management Limited. Policy on Research and use of Research Payment Accounts (RPAs)

MiFID II. Inducements. Key Points

MIFID II Conduct Of Business Rules

Managers will be prohibited from receiving any third-party inducements 1, unless an exception applies.

MiFID II Retail Costs and Charges: Guideline Q&As

Managers will be prohibited from receiving any third-party inducements 1, unless an exception applies.

Public consultation by the AMF on the new rules for the funding of research by investment firms under MiFID II

World Platinum Investment Council (WPIC) Research in a MiFID II Context Asset Manager Compliance Department Edition

CONFLICTS OF INTEREST POLICY. First State Investments EMEA

The new agenda conflicts and inducements. Imogen Garner, Partner Charlotte Henry, Senior Associate Norton Rose Fulbright LLP 6 July 2016

Financial Regulatory Alert

Inducements under MiFID

Directive 2011/61/EU on Alternative Investment Fund Managers

MiFID II for Non-EU Investment Banks, Brokers and Fund Managers

Information on Investment Services and Financial Instruments. December 2017

OCTOBER 2017 MIFID II GUIDE FOR FINANCIAL INVESTMENT ADVISORS

Inducements under MiFID

Enhanced protection for retail investors: MiFID II and MiFIR

AIFM toolbox. AIFM toolbox - May Updated version

Position AMF Recommendation Guide to the organisation of the risk management system within asset management companies DOC

MiFID II inducement rule: the impact on investment research and market commentary

Questions and Answers On MiFID II and MiFIR investor protection and intermediaries topics

MIFID 2: Inducements

COMMISSION DELEGATED REGULATION (EU) /... of

MiFID II Academy: Information and reporting to clients. Floortje Nagelkerke 21 November 2017

Directive 2011/61/EU on Alternative Investment Fund Managers

Questions and Answers On MiFID II and MiFIR investor protection and intermediaries topics

OUR APPROACH TO INDUCEMENTS. Under Markets in Financial Instruments Directive II (MiFID II)

Accepted market practice (AMP) on Liquidity Contracts

MiFID II / MiFIR seminar Break-out session 1: Retail conduct investor protection

Position AMF Recommendation Guide to the organisation of the risk management system within asset management companies DOC

The impact of MiFID II on AIFMD investment managers

FINAL NOTICE For the reasons given in this notice, the Authority hereby imposes on Sesame a financial penalty of 1,598,000.

Briefing Note for BIPAR National Member Associations

MiFID 2/MiFIR Articles relevant to article The top 10 things every commodities firm needs to know about MiFID 2

MiFID 2 COSTS AND CHARGES

Policy for the Management of Conflicts of Interest

MUFG Lux Management Company S.A. Inducements Policy. Compliance Version 1.0

Official Journal of the European Union L 341. Legislation. Non-legislative acts. Volume December English edition. Contents REGULATIONS

DIRECTIVES. (Text with EEA relevance)

MiFID II challenges for Wealth Managers

Questions and Answers On ESMA s temporary product intervention measures on the marketing, distribution or sale of CFDs and Binary options to retail

MiFID II Review of FCA Policy Statement 17/14

Questions and Answers. On the Benchmarks Regulation (BMR)

Consultation Paper. ESMA Guidelines on enforcement of financial information. 19 July 2013 ESMA/2013/1013

Questions and Answers On MiFID II and MiFIR transparency topics

PRODUCT GOVERNANCE POLICY V X Spot Markets (EU) Ltd.

Consultation Paper RTS specifying the scope of the consolidated tape for non-equity financial instruments

Investment Funds sourcebook. Chapter 3. Requirements for alternative investment fund managers

The Perimeter Guidance Manual. Chapter 13. Guidance on the scope of MiFID and CRD IV

Questions and Answers. On the Benchmarks Regulation (BMR)

Information page Alternative Investment Fund Managers Directive Operating conditions - General

A) Information on the Company and the investment services it offers

INDEPENDENT FRANCHISE PARTNERS VARIABLE CAPITAL COMPANY PLC. (the "Fund") UCITS V Remuneration Policy

EUROPEAN UNION. Brussels, 13 May 2011 (OR. en) 2009/0064 (COD) PE-CONS 60/10 EF 181 ECOFIN 738 CODEC 1293

BlackRock Institutional Trust Company, National Association (UK Branch)

Questions and Answers. On the Market Abuse Regulation (MAR)

Our Investment Services

Questions and Answers. On the Benchmarks Regulation (BMR)

INVESTMENT SERVICES RULES FOR INVESTMENT SERVICES PROVIDERS

POLICY FOR THE FUNDING OF THIRD-PARTY RESEARCH

Questions and Answers On MiFID II and MiFIR transparency topics

INVESTMENT SERVICES RULES FOR INVESTMENT SERVICES PROVIDERS

Statement on Best Execution Principles of Credit Suisse Asset Management (Switzerland) Ltd.

MiFID 2/MiFIR Articles relevant to article The top 10 things every commodities firm needs to know about MiFID 2

Order Execution Policy. January 2018 v1

Use of UK data in ESMA databases and performance of MiFID II calculations in case of a no-deal Brexit

Approach to Implementation for MiFID II Costs & Charges Disclosures

AIFMD. Fundamental considerations to be addressed at a strategic level for marketing in the EU:

MiFID II: What Are We Waiting For?

The Alternative Investment Fund Managers Directive. Key features & focus on third countries

Flash News. ESMA releases its Final Technical Advice on MiFID II/MiFIR. Background. ESMA Final Technical Advice on investor protection topics

SGAM RESPONSE TO CESR'S PUBLIC CONSULTATION ON INDUCEMENTS UNDER MiFID

CLIENT CATEGORISATION POLICY

MIFID II LEAFLET CORPORATE INVESTMENT BANKING (SGCIB)

ESMA s priorities for the asset management community ALFI European Asset management Conference ESMA s priorities for the asset management community

MIFID II LEAFLET CORPORATE INVESTMENT BANKING (SGCIB)

Countdown to MiFID II: Final rules for trading venues, participants and investment firms

SKANESTAS INVESTMENTS LIMITED PRODUCT GOVERNANCE POLICY

Notes to the Consolidated Financial Statements

MiFID II 31 December MiFID II. Information to clients on costs and charges

Final report. Guidelines on reporting obligations under Articles 3(3)(d) and 24(1), (2) and (4) of the AIFMD ESMA/2013/1339 (revised)

SCOPE OF SECTION C(10) CONTRACTS WHICH ARE "COMMODITY DERIVATIVES" FOR THE PURPOSES OF MIFID II

Questions and Answers On MiFID II and MiFIR post trading topics

Notice for Recipients of This Draft EITF Abstract

Final Report Technical advice on CRA regulatory equivalence CRA 3 update

MiFID2 for asset managers headlines and roadmaps

CIG Fund Management Company Limited Remuneration Policy

INSTRUCTIONS DATA COLLECTION PRUDENTIAL FRAMEWORK INVESTMENT FIRMS TEMPLATE FOR MIFID INVESTMENT FIRMS. 06 July 2017

Supervising retail investment advice: inducements and conflicts of interest

Briefing Note for BIPAR National Member Associations

FIA AND FIA EUROPE SPECIAL REPORT SERIES: OPEN ACCESS - CCPS,

Order Execution Policy 3 rd January 2018

DECISIONS Official Journal of the European Union L 7/3

The King & Spalding Guide to MiFID II Conduct of Business Requirements

AnaCredit Reporting Manual. Part II Datasets and data attributes

Transcription:

Inducements Procedure

EWUB S.A. Inducements Procedure 2 Contents GENERAL PRINCIPLES... 3 REGULATORY BACKGROUND... 3 ESMA guidance... 8 Automated inducement process description... 11 Standard reporting: frequency of reporting... 11 On request reporting: client contract termination... 11 Calculation principles... 11

EWUB S.A. Inducements Procedure 3 GENERAL PRINCIPLES PURPOSE The MiFID II Directive 2014/65 deals with the payment to, and/or receipt from, a third party of inducements in relation to the provision of services to clients of investment firms. In doing so, it distinguishes between the rules that apply to investment services generally, and those that apply specifically in the context of portfolio management and investment advice. Generally, MiFID II permits investment firms to accept inducements in circumstances where certain requirements are satisfied. However, it prohibits inducements paid to, and/or received by, an investment firm carrying out portfolio management or providing investment advice: such firms are only permitted to pay or receive minor non-monetary benefits ( MNBs ) that fulfil certain requirements. Commission Delegated Directive 2017/593 (the Delegated Directive ) contains more detailed rules on inducements, including specific requirements governing inducements in relation to research. The European Securities and Markets Authority (ESMA) also deals with inducements in its Q&A on MiFID II and MiFIR Investor Protection Topics. REGULATORY BACKGROUND Inducements According to Article 24(9) of MiFID II, an investment firm is only permitted to pay, or be paid, an inducement (namely, a fee, commission or non-monetary benefit) in connection with the provision of an investment service or ancillary service where the relevant payment: is designed to enhance the quality of the relevant service to a client of the investment firm; and does not impair compliance with the investment firm s duty to act honestly, fairly and professionally in accordance with the best interests of its clients; In addition, the investment firm must clearly disclose to the client, the existence, nature and amount of the inducement or, where the amount cannot be ascertained, its method of calculation. This disclosure must be made in a manner that is comprehensive, accurate and understandable to the client and must be made prior to the provision of the relevant investment/ancillary service. Where applicable, the investment firm must inform the client on mechanisms for transferring to the client an inducement received in relation to the provision of an investment/ancillary service. Payments or benefits received or provided by an investment firm which enable or are necessary for the provision of investment services and which are inherently incapable of giving rise to conflicts with the investment firm's duties to act honestly, fairly and professionally in accordance with its clients' best interests are not considered to be inducements. This includes, for example, custody costs, settlement and exchange fees, regulatory levies or legal fees. According to the Delegated Directive, an inducement should not be accepted if it results in the provision of the relevant services to the client being biased or distorted.

EWUB S.A. Inducements Procedure 4 EWUB The Delegated Directive also provides further information as to when an inducement will be designed to enhance the quality of the relevant service to the client. Specifically, such an inducement must meet three conditions on an ongoing basis, namely, it must: be justified by the provision of an additional or higher level service to the relevant client, which is proportionate to the level of inducements received the Delegated Directive provides examples of such services; not directly benefit the recipient firm, its shareholder or employees without tangible benefit to the relevant client; and be justified by the provision of an on-going benefit to the relevant client in relation to an on-going inducement. An investment firm must hold evidence that any inducement that it pays or receives is designed to enhance the quality of the relevant service to the client. Regarding disclosure, MNBs may be described in a generic way while other non-monetary benefits must be priced and disclosed separately. Where an investment firm discloses the method of calculating the amount of a payment or benefit in advance of providing the relevant service in its prior disclosure, then it must disclose the exact amount of the payment or benefit on an ex post facto basis. An investment firm must inform its clients on an individual basis about the actual amount of payments or benefits received or paid at least once a year, as long as (on-going) inducements are received by the investment firm in relation to the investment services provided to the relevant clients. Inducement paid: The list of Business Introducers is non exhaustive as it can be updated on a regular basis and at minima confirmed by Private Banking as part of this procedure review. Independent advice and portfolio management MiFID II prohibits an EU investment firm which carries out portfolio management or provides investment advice from accepting and retaining third party inducements (fees, commissions or monetary and non-monetary benefits) in relation to the provision of services to clients. However, such an investment firm may accept MNBs that are: capable of enhancing the quality of service provided to a client; and of a scale and nature such that they could not be judged to impair compliance with the investment firm s duty to act in the best interests of the client. In addition, the investment firm must clearly disclose the relevant MNB. The Delegated Regulation sets out in more detail the benefits that qualify as acceptable MNBs as well as further details on returning inducements to clients and disclosure.

EWUB S.A. Inducements Procedure 5 EWUB Inducement received: In order to maintain an independent investment selection responding best to the needs of the customer, the Bank does not receive any inducement related to discretionary portfolio management activity. Inducement paid: the Bank does not perform any investment advisory service for the time being. Minor non-monetary benefits According to the Delegated Directive, the following benefits qualify as acceptable MNBs: information or documentation relating to a financial instrument or an investment service which is either generic in nature or personalised to reflect the circumstances of an individual client; written material from a third party that is commissioned or paid for by a corporate issuer (or potential issuer) to promote a new issuance by the company, or contractually engaged and paid by the issuer to produce such material on an on-going basis, provided the relationship is clearly disclosed in the material and that the material is simultaneously made available to any investment firm wishing to receive it or to the general public; participation in conferences, seminars and other training events on the benefits and features of a specific financial instrument or an investment service; hospitality of a reasonable de minimis value, such as food and drink during a business meeting or a conference, seminar or the training events mentioned above; and certain other MNBs which a member state deems capable of enhancing the quality of service provided to a client and are of a scale and nature that is unlikely to impair compliance with an investment firm's duty to act in the client's best interests. An MNB, in order to be acceptable, must be reasonable and proportionate and of such a scale that it is unlikely to influence the investment firm s behaviour in any way that is detrimental to the relevant client's interests. In addition an MNB must be disclosed to the clients as a generic information included in any relevant investment service or ancillary service confirmation or correspondence with client (in line with the Gift policy): Please be informed that some minor non-monetary benefits such as participation to conference or other gifts with value less than EUR 250 or equivalent in other currencies might have been received from or granted to business introducer or counterparty as a commercial relationship. This does not impair the independence of EWUB SA as investment or ancillary service provider to its clients. The Delegated Directive imposes additional requirements on an investment firm in relation to the transfer of a third party inducement paid in respect of the provision of independent advice or portfolio management to a client.

EWUB S.A. Inducements Procedure 6 EWUB In order to maintain an independent investment selection responding best to the needs of the customer, the Bank only accepts invitations to conferences and seminars with topics considered relevant to the Bank activities. The following MNBs are acceptable and approved by HR and Management as Training. participation in conferences, seminars and other training events on the benefits and features of a specific financial instrument or an investment service; hospitality of a reasonable de minimis value, such as food and drink during a business meeting or a conference, seminar or the training events mentioned above; Research Inducements According to the Delegated Directive, research provided by a third party to an investment firm may be considered as an inducement under MiFID II. Research will not be an inducement if the firm either directly pays for it out of its own resources, or from a separate research payment account ( RPA ), which is controlled by the investment firm and which meets a number of conditions. In particular, if an RPA is being used, the RPA must be funded by a specific research charge to the client. In addition, as part of establishing an RPA, the investment firm must set up and regularly assess a research budget and then agree with the client: the research charge as budgeted; and the frequency with which the specific research charge will be deducted from the clients resources over the year. The investment firm must regularly assess the quality of the research purchased based on robust quality criteria and its ability to contribute to better investment decisions. In order to do so, the investment firm must establish all necessary elements in a written policy and provide the policy to its clients. When an investment firm makes use of the RPA it must provide its clients with certain information both before the provision of the investment service and annually. Moreover, where the competent authority or a client so requests, the investment firm must provide specified information, including a summary of the providers paid from the RPA, the total amount paid over a defined period and the benefits and services received by the investment firm. Significantly, the Delegated Directive suggests that an investment firm which funds research through an RPA may collect the research charge alongside a transaction commission, provided that the separate costs of the two are clearly distinguished and the payment is not linked to the value/volume of transactions. The purpose of this document is to design a process sufficiently robust to perform a Best Execution when the Bank perform a security transaction for a client as stated by the new regulation MiFID II.

EWUB S.A. Inducements Procedure 7 EWUB The research received from brokers (included in transaction fees) will fall in the scope of inducement. The Bank decided to only use paying researches and publications and to pay for them itself, from a EWUB bank account, without charging it to the clients. The investment research policy describe: i. the research and publications used and received; ii. the set-up of a dedicated payment EWUB account for all paying researches and publications; iii. the controls and remediation actions to ensure no such research costs are paid or supported by clients, and that no other (free) researches are used, qualifying as Research inducements. The publication and research received by GM is paid for by the Bank and not charged to the client. PB only received general financial communication and newsletters, considered public and hence of out Inducement scope.

EWUB S.A. Inducements Procedure 8 ESMA guidance In addition, according to ESMA Q&A issued in June 2017, we note the following items: Payment for Research Research Policy Research Payment Account Unrequested research provided free of charge While a research payment account (RPA) can only be funded by a specific research charge to the client, which must be based on a research budget set by the firm, ESMA considers that a budget can be set for a group of client portfolios or accounts where the firm has established a similar need for third party research in respect of the investment services rendered to its clients. Firms should not set a budget for a group of client portfolios or accounts that do not share sufficiently similar investment objectives and research needs. A firm should be able to clearly evidence and demonstrate its approach to setting and managing a budget for a given group of client accounts and that it is consistent with using the budget in the best interests of its clients, as required by Article 13(6) of the MiFID II Delegated Directive. A firm is still required to identify a specific research charge for individual clients to fund the RPA, even where a budget is set for several portfolios. A firm will therefore need to have a transparent method for making a fair allocation of costs in such cases. This may involve the firm pro-rating the cost of the research budget across all client accounts benefitting from it based, for example, on the value of each client s portfolio, to establish a specific charge for individual clients. A firm may also choose to set a firm-level research budget to help it control overall costs, but this does not replace the need to set budgets for discrete groups of client portfolios and accounts as described above. A firm should describe its approach in a written research policy provided to its clients under Article 13(8) of the MiFID II Delegated Directive. Under Article 13 of the MiFID II Delegated Directive, where an investment firm chooses to use an RPA, this must be funded by a research charge to the client. The nature of this deduction as a charge means that once it is deducted from a client, the funds belong to the firm. However, this research fund should be managed in an RPA controlled by the investment firm and it should be used specifically for purchasing external research to benefit the client. ESMA is of the opinion that it is important that the investment firm makes its best efforts to align as much as possible the timing of the charges paid by the client to the firm, and the expenditure on research paid from the RPA by the firm to the research provider. Firms need to have in place policies and systems to assess the nature of any service, benefit or material paid or provided by any third party to determine whether they can provide or accept it.

EWUB S.A. Inducements Procedure 9 Research received from non-eu firms When a research could be considered a minor non-monetary benefit It is not acceptable for firms to receive research for free where no assessment has been made under the above inducements rules or there is no payment arrangement in place that complies with Article 13 of the MiFID II Delegated Directive. A firm providing independent investment advice or portfolio management services can only receive research in relation to those activities by complying with Article 13 of the MiFID II Delegated Directive. In this context, firms should not accept research for free. In relation to services or activities other than those covered under Articles 24(7) and 24(8), a firm providing or receiving research services must assess whether the provision or receipt of the research service meets the quality enhancement test (and the other conditions in Article 24(9)) or decide whether it intends to pay for the research directly or through a separate RPA under Article 13 Delegated Directive. Where a firm does not want to accept research material, they should take reasonable steps to cease receiving it or avoid benefitting from its content, for example by automatically blocking or filtering certain senders/materials where practicable, and / or requesting a provider to stop providing research, and / or using the compliance function of the firm to monitor, assess and determine whether the material can be accepted before it reaches those parts of the firm that would make use of it. firm could also consider having a process whereby staff can report to compliance or senior management any cases of unsolicited research being provided to them from a third party where no payment arrangement or agreement is in place. Where the provider of research is a firm which also provides execution services under MiFID, and is subject to Article 13(9) of the MiFID II Delegated Directive, the provision of unsolicited (or free ) research would not meet the obligation on them to price services separately, and ensure its supply does not potentially influence the execution services they supply. On that basis, firms should have systems and controls in place to enable them to cease providing unsolicited research. Firms should therefore treat research from a third country provider in the same way as any other third party benefits. EU/EEA firms subject to MiFID II inducements rules must comply with these requirements (Article 24, paragraphs (7), (8) and (9), and the relevant level two provisions) irrespective of the status or geographical location of the research provider. Alternatively, they could receive research using the paying arrangements set out in Article 13 of the MiFID II Delegated Directive. Firms should have in place policies and systems to assess the nature and scale of any service, benefit or material provided by any third party to determine whether it can be considered as a minor nonmonetary benefit or as research subject to Article 13 requirements.

EWUB S.A. Inducements Procedure 10 Research related to fixed income, currencies or commodities (FICC) Non-substantive material or services consisting of short term market commentary on the latest economic statistics or company results that firms providing independent investment advice or portfolio management may treat as minor non-monetary benefits. For any third party benefits to be an acceptable minor non-monetary benefits, a firm should assess and ensure they are reasonable and proportionate and of such a scale that they are that they are unlikely to influence the firm s behaviour in any way that is detrimental to the interest of the relevant client. Short market updates with limited commentary or opinion may be capable of being considered as information that is a minor nonmonetary benefit consistent with Recital 29 and Article 12(3)(a) of the MiFID II Delegated Directive. Material repeating or summarising public news stories or public statements from corporate issuers (e.g. public quarterly results reports or other market announcements) could also be considered as information that constitutes a minor non-monetary benefit. A minor non-monetary benefit can include written material from a third party that is commissioned and paid for by a corporate issuer or potential issuer to promote a new issuance by the company provided that the relationship is clearly disclosed in the material and that the material is made available at the same time to any investment firms wishing to receive it or to the general public. This exemption can allow investment firms to receive pre-deal material directly relating to a new capital raising event by an issuer, which is produced by a third party such as another investment firm who is placing and / or underwriting the issue (often referred to as connected research ), provided that the nature of the material is made clear and it is available at the same time to any prospective investor. Article 12(3)(b) also allow investment firms to accept material from a third party where they are contractually engaged and paid by the issuer to produce such material on an ongoing basis, again subject to the relationship being clearly disclosed within it and the material being made available at the same time to any investment firms wishing to receive it or to the general public. Recital 30 of the MiFID II Delegated Directive finally clarifies that any non-monetary benefit that involves a third party allocating valuable resources to the investment firm shall not be considered as minor and shall be judged to impair compliance with the investment firm's duty to act in their client s best interest. MiFID II inducements restrictions in Article 24(7) and (8) do not provide any carve out for third party analytical work on fixed income, currencies and commodities (FICC) or other assets. However, depending on its nature, specific material relating to FICC markets may be capable of being either research that would be acceptable if received in accordance with Article 13 of the Delegated Directive, or a minor non-monetary benefit under Article 12 of the same.

EWUB S.A. Inducements Procedure 11 Automated inducement process description The process of inducement computation in T24 is done based on commission rates per Business Introducer (hereafter BI ) applied to AuM or revenues in T24 The inducement are of 3 mains types: one-off fixed commission of EUR x x% of AuM, calculated in T24 as Client AuM in Local Currency (EUR) * Commission rate per Business introducer*period x%> of revenue, calculated in T24 as EWUB revenue on Client in Local Currency (EUR) * Commission rate per Business introducer*period Some additional conditions might apply in specific cases: the above rules can be applied cumulatively (i.e. some BI can have only one of the above or mix of the above); it is possible that the % of AuM and/or revenue declines (e.g. a BI receives 30% in year 1, 25% in year 2, 20% in year 3 and 0% afterwards). Further details on the automated inducement computation and controls in T24 are described in the Business Requirements Definitions ( BRD ) given to IT in December 2017 for development. Standard reporting: frequency of reporting MiFID II requires to send the inducement reports to clients at least once a year. EWUB has chosen to produce one report per year. After receiving the standard inducement report, the client can ask for more detailed breakdown. This breakdown will be based on a period of the last standard report he has received. The first inducement reports will be sent at the end of Q1 2019 for the reporting period from January 1 st 2018 to December 31 st 2018. On request reporting: client contract termination If a client decides to end his relation with EWUB, the bank must provide an inducement fees report showing all inducements fees paid to BI (if applicable) from the first day of the current reporting period to the date of contract termination. This can be done at the time of the termination or at the end of the reporting period (year-end). Calculation principles Inducements fees must be expressed in amount. In order to calculate the costs in percentage, the Daily average portfolio value (DAPV) will be used as denominator. For client coming via BI, this figure equals the value of client average AuM at of client s portfolio including average cash balance on portfolio-related cash accounts and deposits and is calculated in portfolio currency. For Execution/Advisory/Custody/Settlement this figure equals the value of Daily Average Assets in clients portfolios. This figure should not take into account cash balance and deposits on portfolio-related cash accounts and should be calculated in portfolio currency.

EWUB S.A. Inducements Procedure 12 When no cost is indicated under a category (not applicable because of the tariff structure of EWUB or because of the nature of service or instrument) or no cost was recorded over the period, 0 should be displayed as the total cost for this category / cost item.